InfuSystem Holdings Files 8-K for Regulation FD Disclosure
Ticker: INFU · Form: 8-K · Filed: Mar 8, 2024 · CIK: 1337013
| Field | Detail |
|---|---|
| Company | Infusystem Holdings, INC (INFU) |
| Form Type | 8-K |
| Filed Date | Mar 8, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, disclosure, regulation-fd
TL;DR
InfuSystem Holdings filed an 8-K for a Reg FD disclosure on March 8, 2024.
AI Summary
InfuSystem Holdings, Inc. filed an 8-K on March 8, 2024, to report a Regulation FD Disclosure. The filing does not contain specific details about the nature of the disclosure, but it is a current report filed under the Securities Exchange Act of 1934.
Why It Matters
This filing indicates InfuSystem Holdings is making a public disclosure under Regulation FD, which requires companies to share material information broadly and simultaneously.
Risk Assessment
Risk Level: low — The filing is a standard procedural disclosure and does not contain information that inherently increases risk.
Key Players & Entities
- InfuSystem Holdings, Inc. (company) — Registrant
- March 8, 2024 (date) — Date of Report
- Regulation FD (regulation) — Type of Disclosure
- Delaware (jurisdiction) — State of Incorporation
- Rochester Hills, Michigan (location) — Principal Executive Offices
FAQ
What specific information is being disclosed under Regulation FD?
The filing does not specify the exact nature of the Regulation FD disclosure, only that it is being made.
When was this 8-K filing submitted?
The 8-K filing was submitted on March 8, 2024.
What is the primary purpose of this 8-K filing?
The primary purpose is to report a Regulation FD Disclosure.
What is the principal executive office address for InfuSystem Holdings, Inc.?
The principal executive office is located at 3851 West Hamlin Road, Rochester Hills, Michigan 48309.
Under which section of the Securities Exchange Act is this report filed?
This report is filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
Filing Stats: 564 words · 2 min read · ~2 pages · Grade level 11 · Accepted 2024-03-08 06:31:20
Filing Documents
- infu-20240308.htm (8-K) — 28KB
- exhibit991announcementofea.htm (EX-99.1) — 7KB
- infusystem_safesmarttruste.jpg (GRAPHIC) — 760KB
- 0001628280-24-009780.txt ( ) — 1197KB
- infu-20240308.xsd (EX-101.SCH) — 2KB
- infu-20240308_lab.xml (EX-101.LAB) — 21KB
- infu-20240308_pre.xml (EX-101.PRE) — 12KB
- infu-20240308_htm.xml (XML) — 3KB
01 - Regulation FD
Item 7.01 - Regulation FD On March 8, 2024 , InfuSystem Holdings, Inc. (the "Company") issued a press release announcing that the Company will disclose its preliminary financial results for the fourth quarter and fiscal year 2023 on Thursday, March 14, 2024 before the market opens. The Company will also conduct a conference call for all interested investors on Thursday, March 14, 2024 at 9:00 a.m. Eastern Time. The press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K. The information furnished in this Item 7.01 — "Regulation FD Disclosure" of this Current Report on Form 8-K and the press release attached hereto as Exhibit 99.1 shall not be deemed "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of such section, and shall not be deemed to be incorporated by reference into the filings of the Company under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended.
01 - Financial Statements and Exhibits
Item 9.01 - Financial Statements and Exhibits (d) Exhibits Exhibit No. Description 99.1 Press Release of InfuSystem Holdings, Inc. dated March 8 , 202 4 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934 the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. INFUSYSTEM HOLDINGS, INC. By: /s/ Richard DiIorio Richard DiIorio Chief Executive Officer and Director Dated: March 8, 2024